You are here

  • Home
  • Archive
  • Volume 5, Issue 1
  • Evaluation of amnion-derived mesenchymal stem cells for treatment-resistant moderate Crohn’s disease: study protocol for a phase I/II, dual-centre, open-label, uncontrolled, dose–response trial

Article metrics

Article menu

Download PDFPDF

XML
Inflammatory bowel disease
Evaluation of amnion-derived mesenchymal stem cells for treatment-resistant moderate Crohn’s disease: study protocol for a phase I/II, dual-centre, open-label, uncontrolled, dose–response trial

 

Online download statistics by month:

Online download statistics by month: May 2018 to March 2024

AbstractFullPdf
May 2018770
Jun 201823623454
Jul 201828828619
Aug 2018100998
Sep 2018575711
Oct 2018403918
Nov 2018434319
Dec 2018484812
Jan 2019403810
Feb 2019565612
Mar 2019757525
Apr 2019545413
May 201942429
Jun 2019464517
Jul 201942409
Aug 2019353610
Sep 201939409
Oct 2019303010
Nov 2019141315
Dec 2019454525
Jan 2020333216
Feb 2020323112
Mar 202040408
Apr 202027277
May 202035339
Jun 202023233
Jul 202037355
Aug 202012136
Sep 202028293
Oct 2020484713
Nov 2020252512
Dec 202021225
Jan 202132319
Feb 2021242511
Mar 2021373314
Apr 2021302510
May 202121175
Jun 202119176
Jul 2021201910
Aug 202118176
Sep 202113119
Oct 2021312930
Nov 2021262518
Dec 202122226
Jan 202218183
Feb 202217159
Mar 202213118
Apr 202213125
May 202219206
Jun 202229279
Jul 202214145
Aug 202229296
Sep 2022313012
Oct 2022161611
Nov 2022242310
Dec 2022424217
Jan 20231351387
Feb 202318186
Mar 202324238
Apr 2023222210
May 202312212211
Jun 202357572
Jul 2023151510
Aug 2023151412
Sep 202315154
Oct 202325268
Nov 2023343112
Dec 202322224
Jan 202429287
Feb 202416169
Mar 2024552913
Total28602788762